Literature DB >> 21565400

The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH.

Hyo Young Kim1, Seunghoo Kim, Hyewon Youn, June-Key Chung, Dong Hae Shin, Kyunglim Lee.   

Abstract

We show here, that the proapoptotic peptide, KLAKLAKKLAKLAK (KLA), which by itself does not penetrate cell membranes, can do so when fused to a protein transduction domain derived from NH(2)-terminus of translationally controlled tumor protein (TCTP-PTD, MIIYRDLISH). Once inside the cell, the conjugated KLA exerts its proapoptotic activity to inhibit tumor growth. We evaluated the cellular uptake of KLA fused to TCTP-PTD (hereafter called TCTP-KLA) and its effect on cancer cell viability. The IC(50) of TCTP-KLA was between 7 and 10 μmol/L. We also evaluated its anti-tumor activity in vivo by injecting it into xenografts of lung carcinoma in Balb/c nude mice. Tumor growth inhibition resulting from treatment with TCTP-KLA was better than that of TAT-KLA. These results suggest that TCTP-KLA can be applied to design cancer therapeutics.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565400     DOI: 10.1016/j.biomaterials.2011.03.074

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

Review 1.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.

Authors:  Wang Qifan; Ning Fen; Xue Ying; Feng Xinwei; Du Jun; Zhang Ge
Journal:  Tumour Biol       Date:  2016-02-11

Review 3.  Cell-penetrating peptides: achievements and challenges in application for cancer treatment.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Kyuri Lee; Youngro Byun; Allan E David; Huining He; Victor C Yang
Journal:  J Biomed Mater Res A       Date:  2013-07-30       Impact factor: 4.396

4.  Fabrication of self-assembled peptide nanoparticles for in vitro assessment of cell apoptosis pathway and in vivo therapeutic efficacy.

Authors:  Syed Faheem Askari Rizvi; Shuai Mu; Chunyan Zhao; Haixia Zhang
Journal:  Mikrochim Acta       Date:  2022-01-08       Impact factor: 5.833

5.  Fluoroalkylation promotes cytosolic peptide delivery.

Authors:  Guangyu Rong; Changping Wang; Lijie Chen; Yang Yan; Yiyun Cheng
Journal:  Sci Adv       Date:  2020-08-12       Impact factor: 14.136

6.  Improved bioactivity of antimicrobial peptides by addition of amino-terminal copper and nickel (ATCUN) binding motifs.

Authors:  M Daben Libardo; Jorge L Cervantes; Juan C Salazar; Alfredo M Angeles-Boza
Journal:  ChemMedChem       Date:  2014-05-06       Impact factor: 3.466

7.  Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.

Authors:  Bo Fu; Wei Long; Ying Zhang; Aifeng Zhang; Fengqin Miao; Yuqing Shen; Ning Pan; Guangming Gan; Fang Nie; Youji He; Jianqiong Zhang; Gaojun Teng
Journal:  Sci Rep       Date:  2015-01-26       Impact factor: 4.379

8.  Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.

Authors:  Hu Wang; Jie-Lan Ma; Ying-Gui Yang; Yang Song; Jiao Wu; Yan-Yan Qin; Xue-Li Zhao; Jun Wang; Li-Li Zou; Jiang-Feng Wu; Jun-Ming Li; Chang-Bai Liu
Journal:  Oncotarget       Date:  2016-08-02

9.  Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide.

Authors:  Chanju Lee; Hyunju Jeong; Younghyeon Bae; Kyungmoon Shin; Sinwoo Kang; Hwikyung Kim; Jayoung Oh; Hyunsu Bae
Journal:  J Immunother Cancer       Date:  2019-06-07       Impact factor: 13.751

10.  TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL.

Authors:  Stéphanie Thébault; Morgane Agez; Xiaoke Chi; Johann Stojko; Vincent Cura; Stéphanie B Telerman; Laurent Maillet; Fabien Gautier; Isabelle Billas-Massobrio; Catherine Birck; Nathalie Troffer-Charlier; Teele Karafin; Joane Honoré; Andrea Senff-Ribeiro; Sylvie Montessuit; Christopher M Johnson; Philippe Juin; Sarah Cianférani; Jean-Claude Martinou; David W Andrews; Robert Amson; Adam Telerman; Jean Cavarelli
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.